Although most of our mouse models develop sarcomas, the A3B mutational signature is most frequently found in breast cancer, lung cancer, urinary cancer, head and neck cancer, and multiple myeloma, and such differences in the type of tumor could be the reason why we were unable to see the effect of A3B in tumor development. This evidence concerns the gene APOBEC3B and breast cancer.